Chemicals · Founded 1976 · www.dacl.co.in · BSE 500120 · NSE DIAMINES&CHM · ISIN INE591D01014
No Notes Added Yet
Business
Diamines & Chemicals Ltd. (DCL) is an Indian manufacturer of specialty chemicals, primarily focusing on methylamines and ethylamines, along with their derivatives. These amines serve as crucial building blocks and intermediates for a diverse range of industries, including pharmaceuticals, agrochemicals, water treatment, dyes and intermediates, rubber chemicals, and polyurethanes. The company operates on a business-to-business (B2B) model, manufacturing these essential chemicals and supplying them to other industrial customers for further processing into finished products. Its core business revolves around chemical synthesis, process optimization, and catering to the specific needs of various industrial sectors.
Revenue Mix
The company's primary business segment is the manufacturing and sale of various types of methylamines (Monomethylamine, Dimethylamine, Trimethylamine) and ethylamines (Monoethylamine, Diethylamine, Triethylamine), and their derivatives. While specific revenue contributions from individual product lines or end-user industries are not typically disclosed publicly, the entire revenue stream is derived from the production and sale of these amine-based chemicals.
Industry
Diamines & Chemicals operates within the Indian specialty chemicals industry, which is a significant and growing sector globally. India is emerging as a preferred manufacturing hub for chemicals, driven by factors like cost competitiveness, skilled labor, and government support for 'Make in India' initiatives. DCL is positioned as an established domestic manufacturer of essential amines, competing with larger domestic players like Balaji Amines and Alkyl Amines, as well as with imports. The amines market requires technical expertise and adherence to stringent quality standards, allowing DCL to cater to specialized industrial requirements.
MOAT
DCL's competitive advantages stem from:
Process Expertise: Over four decades of experience in amine chemistry, indicating deep technical know-how and established manufacturing processes.
Customer Relationships: Long-standing relationships with diverse industrial clients across critical sectors like pharma and agrochemicals.
Entry Barriers: Chemical manufacturing, especially involving hazardous materials like amines, entails high capital expenditure, stringent regulatory compliance, and environmental clearances, which act as deterrents for new entrants.
Niche Focus: A dedicated focus on amines provides specialization and allows for optimization of production.
Growth Drivers
Growing End-User Industries: Sustained growth in key downstream sectors such as pharmaceuticals, agrochemicals, and water treatment, which are major consumers of amines.
Import Substitution: Government impetus and industry focus on reducing reliance on chemical imports, creating opportunities for domestic manufacturers.
Capacity Expansion/Product Diversification: Potential for increasing existing production capacities or introducing new value-added amine derivatives to meet increasing demand and cater to new applications.
"China Plus One" Strategy: Global supply chain diversification encouraging international customers to source chemicals from India.
Risks
Raw Material Price Volatility: Key feedstocks like methanol, ammonia, and ethanol are derivatives of crude oil or other commodities, making raw material costs subject to global price fluctuations.
Intense Competition: Competition from larger domestic players with greater scale and potentially from cheaper imports can impact pricing power and market share.
Environmental & Regulatory Compliance: The chemical industry is subject to evolving and strict environmental regulations, requiring significant capital expenditure for compliance and potential operational disruptions.
Economic Downturn: A slowdown in the broader economy or specific end-user industries (e.g., pharma, agro) could lead to reduced demand for its products.
Technological Obsolescence: Continuous need to invest in R&D and process upgrades to remain competitive and meet evolving customer needs.
Management & Ownership
Diamines & Chemicals Ltd. is promoted by the S.K. Kapadia Group, which has a long history of involvement with the company since its inception. As of December 2023, the promoter group holds a significant stake of approximately 74.99%, indicating strong control and long-term commitment to the business. The management typically comprises experienced professionals with a background in chemical manufacturing and business operations.
Outlook
Diamines & Chemicals is well-positioned to benefit from the growing demand for specialty chemicals in India, driven by the expansion of key end-user industries like pharma and agrochemicals, coupled with government initiatives promoting domestic manufacturing. Its long-standing presence and process expertise in amine chemistry provide a solid foundation. However, the company faces inherent challenges common to the chemical industry, including volatility in raw material prices, intense competition from both domestic and international players, and stringent environmental regulations. Its ability to manage these risks effectively, coupled with potential capacity expansions or diversification into higher-margin derivatives, will be crucial for sustained growth in a competitive landscape.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 29 | 17 | 19 | 18 | 18 | 12 | 9 | 8 | 9 | 14 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Total Income | 30 | 17 | 20 | 18 | 19 | 14 | 10 | 8 | 10 | 15 |
| Total Expenditure | 26 | 18 | 16 | 16 | 16 | 16 | 13 | 10 | 12 | 14 |
| Operating Profit | 4 | -1 | 4 | 2 | 3 | -2 | -3 | -2 | -2 | 1 |
| Interest | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | -2 | 3 | 1 | 2 | -3 | -4 | -3 | -3 | -0 |
| Provision for Tax | 1 | 0 | 1 | 0 | 0 | -0 | -0 | -0 | -1 | 0 |
| Profit After Tax | 2 | -2 | 3 | 1 | 1 | -3 | -4 | -3 | -2 | -0 |
| Adjustments | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | 2 | -2 | 2 | 1 | 1 | -3 | -4 | -3 | -2 | -0 |
| Adjusted Earnings Per Share | 2.3 | -1.8 | 2.5 | 0.8 | 1.3 | -2.9 | -4.2 | -3.5 | -2.4 | -0.1 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 57 | 44 | 39 | 36 | 0 | 63 | 66 | 111 | 104 | 71 | 38 | 40 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 3 | 3 | 3 | 4 | 4 |
| Total Income | 58 | 44 | 39 | 36 | 0 | 65 | 68 | 113 | 107 | 75 | 42 | 43 |
| Total Expenditure | 50 | 38 | 34 | 31 | 0 | 38 | 44 | 55 | 81 | 66 | 52 | 49 |
| Operating Profit | 8 | 6 | 5 | 5 | 0 | 28 | 24 | 58 | 25 | 9 | -10 | -6 |
| Interest | 4 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 3 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 0 | -0 | 0 | 0 | 26 | 22 | 56 | 22 | 5 | -14 | -10 |
| Provision for Tax | 0 | 0 | 1 | -0 | 0 | 5 | 5 | 14 | 6 | 2 | -1 | -1 |
| Profit After Tax | 1 | 0 | -2 | 0 | 0 | 21 | 17 | 42 | 16 | 3 | -13 | -9 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | 0 |
| Profit After Adjustments | 1 | 0 | -2 | 0 | 0 | 21 | 17 | 42 | 15 | 3 | -13 | -9 |
| Adjusted Earnings Per Share | 1.4 | 0.4 | -1.6 | 0.3 | 0 | 21.5 | 17.1 | 42.8 | 15.8 | 2.8 | -12.7 | -10.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -46% | -30% | -10% | -4% |
| Operating Profit CAGR | -211% | NAN% | NAN% | NAN% |
| PAT CAGR | -533% | NAN% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -19% | -21% | -3% | 17% |
| ROE Average | -8% | 2% | 12% | 9% |
| ROCE Average | -8% | 4% | 17% | 14% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 34 | 34 | 33 | 33 | 0 | 85 | 100 | 135 | 148 | 161 | 157 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 3 | 5 | 7 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7 | 6 | 6 | 7 | 0 | 4 | 4 | 4 | 4 | 5 | 3 |
| Total Current Liabilities | 26 | 22 | 19 | 16 | 0 | 6 | 6 | 13 | 10 | 12 | 14 |
| Total Liabilities | 71 | 67 | 65 | 59 | 0 | 95 | 111 | 151 | 163 | 178 | 174 |
| Fixed Assets | 33 | 32 | 29 | 27 | 0 | 22 | 38 | 40 | 65 | 64 | 65 |
| Other Non-Current Assets | 11 | 12 | 12 | 13 | 0 | 16 | 19 | 42 | 22 | 25 | 37 |
| Total Current Assets | 26 | 24 | 23 | 19 | 0 | 56 | 54 | 69 | 75 | 90 | 73 |
| Total Assets | 71 | 67 | 65 | 59 | 0 | 95 | 111 | 151 | 163 | 178 | 174 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 3 | 3 | 22 |
| Cash Flow from Operating Activities | 16 | 3 | 2 | 7 | 0 | 15 | 27 | 16 | 22 | -5 | -11 |
| Cash Flow from Investing Activities | -5 | 1 | 1 | 0 | 0 | -15 | -21 | -9 | -19 | 15 | -29 |
| Cash Flow from Financing Activities | -11 | -4 | -3 | -7 | 0 | -4 | -5 | -6 | -3 | 10 | 18 |
| Net Cash Inflow / Outflow | -0 | -0 | -0 | -0 | 0 | -3 | 1 | 2 | -0 | 19 | -22 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 3 | 22 | 0 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.38 | 0.4 | -1.63 | 0.25 | 0 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 | -12.72 |
| CEPS(Rs) | 3.82 | 2.88 | 0.45 | 2.28 | 0 | 23.29 | 18.79 | 44.66 | 19.15 | 6.59 | -8.72 |
| DPS(Rs) | 0.5 | 0 | 0 | 0 | 0 | 5 | 3 | 6 | 2.5 | 1 | 0 |
| Book NAV/Share(Rs) | 31.65 | 32.05 | 30.31 | 30.64 | 0 | 86.87 | 102.41 | 137.43 | 151.36 | 151.9 | 156.41 |
| Core EBITDA Margin(%) | 12.16 | 11.84 | 11.38 | 11.29 | 0 | 39.98 | 33.32 | 50.23 | 21.8 | 7.61 | -35.88 |
| EBIT Margin(%) | 8.78 | 7.52 | 7.1 | 7.17 | 0 | 41.2 | 33.56 | 51.1 | 21.52 | 7.16 | -35.47 |
| Pre Tax Margin(%) | 2.81 | 0.88 | -0.78 | 0.2 | 0 | 41.08 | 33.43 | 50.97 | 21.33 | 6.69 | -36.27 |
| PAT Margin (%) | 2.11 | 0.79 | -3.69 | 0.63 | 0 | 33.42 | 25.28 | 37.9 | 15.27 | 4.13 | -32.61 |
| Cash Profit Margin (%) | 5.85 | 5.73 | 1.02 | 5.66 | 0 | 36.26 | 27.81 | 39.52 | 18.01 | 9.02 | -22.78 |
| ROA(%) | 1.81 | 0.56 | -2.41 | 0.4 | 0 | 27.26 | 16.28 | 32.04 | 10.13 | 1.73 | -7.12 |
| ROE(%) | 4.41 | 1.25 | -5.23 | 0.83 | 0 | 36.53 | 18.05 | 35.72 | 11.25 | 1.99 | -8.2 |
| ROCE(%) | 10.48 | 7.28 | 6.08 | 5.94 | 0 | 39.57 | 23.92 | 48.14 | 15.84 | 3.31 | -8.35 |
| Receivable days | 59.11 | 68.34 | 66.99 | 70.12 | 0 | 48.85 | 53.69 | 54.32 | 69.45 | 77.98 | 91.59 |
| Inventory Days | 87.57 | 89.09 | 103.47 | 98.31 | 0 | 63.11 | 40.97 | 31.58 | 59.98 | 125.2 | 284.71 |
| Payable days | 69.43 | 74.52 | 63.14 | 48.41 | 0 | 55.48 | 49.41 | 69.01 | 49.75 | 74.05 | 101.44 |
| PER(x) | 17.86 | 52.7 | 0 | 132.58 | 0 | 12.31 | 15.91 | 9.38 | 31.83 | 112.33 | 0 |
| Price/Book(x) | 0.78 | 0.65 | 0.9 | 1.1 | 0 | 3.04 | 2.65 | 2.92 | 3.33 | 2.06 | 1.49 |
| Dividend Yield(%) | 2.03 | 0 | 0 | 0 | 0 | 1.89 | 1.1 | 1.49 | 0.5 | 0.32 | 0 |
| EV/Net Sales(x) | 0.72 | 0.89 | 1.18 | 1.35 | 0 | 3.6 | 3.41 | 3.31 | 4.37 | 3.71 | 5.45 |
| EV/Core EBITDA(x) | 5.19 | 6.42 | 9.06 | 9.94 | 0 | 8.17 | 9.45 | 6.28 | 18.01 | 30.81 | -21.25 |
| Net Sales Growth(%) | -14.15 | -23.46 | -11.03 | -9 | -100 | 76.57 | 5.24 | 67.24 | -5.91 | -31.3 | -46.16 |
| EBIT Growth(%) | -34.32 | -34.1 | -17.02 | -7.69 | -100 | 814.09 | -14.29 | 154.68 | -60.38 | -77.13 | -366.62 |
| PAT Growth(%) | -61.74 | -71.15 | -510.02 | 115.57 | -100 | 8355.42 | -20.39 | 150.74 | -62.09 | -81.41 | -524.8 |
| EPS Growth(%) | -61.74 | -71.15 | -509.99 | 115.57 | -100 | 8355.56 | -20.39 | 150.72 | -63.08 | -82.35 | -555.6 |
| Debt/Equity(x) | 0.63 | 0.63 | 0.68 | 0.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 |
| Current Ratio(x) | 1 | 1.1 | 1.2 | 1.19 | 0 | 9.6 | 8.43 | 5.44 | 7.29 | 7.36 | 5.12 |
| Quick Ratio(x) | 0.56 | 0.54 | 0.58 | 0.62 | 0 | 7.46 | 8.07 | 4.11 | 5.61 | 4.76 | 3.12 |
| Interest Cover(x) | 1.47 | 1.13 | 0.9 | 1.03 | 0 | 343.24 | 259.45 | 390.43 | 114.74 | 15.06 | -44.11 |
| Total Debt/Mcap(x) | 0.81 | 0.96 | 0.76 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.87 | 54.87 | 54.87 | 55.18 | 55.2 | 55.2 | 55.34 | 57.4 | 57.5 | 57.57 |
| FII | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.08 | 0 | 0 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 45.1 | 45.1 | 45.09 | 44.77 | 44.76 | 44.77 | 44.64 | 42.5 | 42.48 | 42.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.58 | 0.58 | 0.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.43 | 0.43 | 0.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 1.01 | 1.01 | 1.01 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -46% | -30% | -10% | -4% |
| Operating Profit CAGR | -211% | 0% | 0% | 0% |
| PAT CAGR | -533% | 0% | 0% | 0% |
| Share Price CAGR | -19% | -21% | -3% | +17% |
| ROE Average | -8% | +2% | +12% | +9% |
| ROCE Average | -8% | +4% | +17% | +14% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.87 | 54.87 | 54.87 | 55.18 | 55.2 | 55.2 | 55.34 | 57.4 | 57.5 | 57.57 |
| FII | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.08 | 0 | 0 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 45.1 | 45.1 | 45.09 | 44.77 | 44.76 | 44.77 | 44.64 | 42.5 | 42.48 | 42.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.58 | 0.58 | 0.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.43 | 0.43 | 0.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 1.01 | 1.01 | 1.01 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.